Literature DB >> 20005544

Effects of glucose and insulin on acyl ghrelin and desacyl ghrelin, leptin, and adiponectin in pregnant women with diabetes.

William Gibson1, Jianhua Liu, Bruce Gaylinn, Michael O Thorner, Graydon S Meneilly, Sandra L Babich, David Thompson, Jean-Pierre Chanoine.   

Abstract

The aim of the study was to compare the regulation of ghrelin, leptin, and adiponectin by insulin and glucose during the second and third trimesters of pregnancy in women with diabetes. We studied 9 pregnant women with diabetes. All women were treated with insulin and omitted the morning dose on the day of the test. After collection of baseline fasting samples, we performed 3 successive glucose clamps: 2 euglycemic clamps (glucose, 5 mmol/L; insulin infusion at 20 and 40 mU m(-2) min(-1)) and 1 hyperglycemic clamp (glucose, 10 mmol/L; insulin infusion at 40 mU m(-2) min(-1)). We determined concentrations of acyl and desacyl ghrelin (using a double-antibody sandwich assay that recognizes the full-length molecule), leptin, and adiponectin. Fasting desacyl ghrelin concentrations decreased, whereas insulin and leptin concentrations increased, between the second and third trimesters of pregnancy (P < or = .011). During the clamp studies, desacyl ghrelin concentrations decreased by 33% (second trimester, P = .004) and 27% (third trimester, P = .09) with increasing glucose and insulin concentrations, whereas acyl ghrelin, leptin, and adiponectin concentrations were unaffected. Glucose and insulin regulate desacyl ghrelin concentrations in pregnant women with diabetes. Impaired desacyl ghrelin regulation may affect energy metabolism in pregnant women with poorly controlled diabetes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005544      PMCID: PMC2975459          DOI: 10.1016/j.metabol.2009.09.033

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

1.  Post-prandial decrease of circulating human ghrelin levels.

Authors:  M Tschöp; R Wawarta; R L Riepl; S Friedrich; M Bidlingmaier; R Landgraf; C Folwaczny
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

3.  Ghrelin enhances appetite and increases food intake in humans.

Authors:  A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Insulin regulates plasma ghrelin concentration.

Authors:  Mohammed F Saad; Basem Bernaba; Chii-Min Hwu; Sujata Jinagouda; Salwa Fahmi; Ella Kogosov; Rima Boyadjian
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

5.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

Authors:  H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

6.  The influence of insulin on circulating ghrelin.

Authors:  Daniel E Flanagan; Mark L Evans; Teresa P Monsod; Frances Rife; Rubina A Heptulla; William V Tamborlane; Robert S Sherwin
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-02       Impact factor: 4.310

7.  The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia.

Authors:  B Fruehwald-Schultes; K M Oltmanns; W Kern; J Born; H L Fehm; A Peters
Journal:  Int J Obes Relat Metab Disord       Date:  2002-04

8.  Circulating ghrelin levels in patients with polycystic ovary syndrome.

Authors:  Christof Schöfl; Rüdiger Horn; Thilo Schill; Hans W Schlösser; Manfred J Müller; Georg Brabant
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

9.  Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients.

Authors:  Christian Anderwald; Georg Brabant; Elisabeth Bernroider; Rüdiger Horn; Attila Brehm; Werner Waldhäusl; Michael Roden
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose.

Authors:  Eiichiro Nakagawa; Noritoshi Nagaya; Hiroyuki Okumura; Mitsunobu Enomoto; Hideo Oya; Fumiaki Ono; Hiroshi Hosoda; Masayasu Kojima; Kenji Kangawa
Journal:  Clin Sci (Lond)       Date:  2002-09       Impact factor: 6.124

View more
  5 in total

1.  The Role of Leptin in Maintaining Plasma Glucose During Starvation.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  Postdoc J       Date:  2018-03

Review 2.  Interrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevance.

Authors:  François Chabot; Alexandre Caron; Mathieu Laplante; David H St-Pierre
Journal:  World J Diabetes       Date:  2014-06-15

3.  The ghrelin O-acyltransferase-ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; F Rotellar; V Valentí; C Silva; C Mugueta; M R Pulido; R Vázquez; J Salvador; M M Malagón; I Colina; G Frühbeck
Journal:  Diabetologia       Date:  2012-08-07       Impact factor: 10.122

4.  Lower Plasma Ghrelin Levels are Found in Women with Diabetes-Complicated Pregnancies.

Authors:  Rita Angélica Gómez-Díaz; Monica P Gómez-Medina; Eleazar Ramírez-Soriano; Lucio López-Robles; Carlos A Aguilar-Salinas; Renata Saucedo; Arturo Zarate; Adan Valladares-Salgado; Niels H Wacher
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-07-20

Review 5.  The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.